MD Anderson Cancer Center · 11 hours ago
Executive Director, Compliance Programs and Quality Assurance
MD Anderson Cancer Center is dedicated to eliminating cancer through integrated patient care, research, and education. The Executive Director, Compliance Programs and Quality Assurance, will oversee the Institutional Compliance Program, ensuring compliance with legal and regulatory standards while leading quality assurance initiatives and educational activities within the organization.
Health CareHealth DiagnosticsHospitalMedical
Responsibilities
Provide the strategic vision for the operation of the Institutional Compliance Program's education, outreach, and policy governance functions; risk assessment initiatives; investigation efforts; intern program; executive reporting; compliance committees; publications and communications; reporting and audit response; and the Institutional Compliance Program's annual Work Plans
Serve as a member of Institutional Compliance's Leadership Committee, comprising the Chief Compliance and Ethics Officer; the Deputy Chief Compliance Officer; the Senior Legal Officers for Privacy and Information Security, Billing and Reimbursement, Research Compliance, Data Governance, and Corporate Compliance and Ethics
Co-chair the Institutional Mandatory Training Steering Committee, which considers proposals and revisions to Institution-wide education requirements including the annual Employee Education Event and the New Employee Orientation Program; and also is responsible for oversight and direction of all general compliance educational activities, including Faculty Compliance Orientation, the annual Employee Education Event, and other general Institution-wide educational activities such as Compliance Training for Managers
Serve on the Institutional Regulatory and Public Safety Work Group to strategize and review software proposals and projects in support of MD Anderson's regulatory goals
Serve on the Institutional Safety Committee to stay abreast of Institution-wide safety efforts and trends, and to provide Institutional Compliance support and direction
Assess, propose enhancements to, and facilitate programmatic changes for all Institutional Compliance Program elements
Assist senior legal officer (SLO) teams on consults and investigations, as needed
Responsible for strategy, leadership for, and management of the Compliance Program Elements: Federal Healthcare Compliance Program Training and Education, General (Enterprise) Compliance Education, Specialized Compliance Education, Compliance Outreach and Awareness, Communications, Compliance Program Documents and Publications, Institutional Compliance Program Website, Internet, and SharePoint Content, Compliance Liaison and Ambassador, Institutional Policy Program, Assurance Activities, Compliance Hotline and related activities, Compliance Plans, Risk Assessment, UT System Reporting, Compliance Committee Structure, Supervisory Functions, Departmental Responsibilities, Special Projects and Collaborative Efforts, Quality Assurance Responsibilities
Qualification
Required
Master's Level Degree
One or more of the following certifications: Certified Fraud Examiner (CFE) issued by the Association of Certified Fraud Examiners (ACFE), Certified in Health Care Compliance (CHC) issued by the Compliance Certification Board (CCB), Editor in the Life Sciences (ELS), Adobe Certified Expert (ACE)
Ten years in health care administration with an emphasis on strategy development, project management, communications, compliance, and assurance, to include five years of supervisory/managerial experience
Preferred
Juris Doctorate Degree
Experience in a leadership position in a NCI-Designated Cancer Center
Certified Fraud Examiner (CFE)
Certified in Health Care Compliance (CHC)
Editor in the Life Sciences (ELS)
Benefits
Medical
Dental
Paid time off
Retirement
Tuition benefits
Educational opportunities
Individual and team recognition
Company
MD Anderson Cancer Center
MD Anderson Cancer Center is a cancer treatment and research institution which gives treatment, and research of all types of cancer.
Funding
Current Stage
Late StageTotal Funding
$16.2MKey Investors
Break Through CancerGastro-Intestinal Research Foundation
2023-05-16Grant· $2.7M
2023-01-24Grant· $3.5M
2022-04-19Grant· $10M
Recent News
Medical Xpress - latest medical and health news stories
2026-01-17
2026-01-16
New Orleans CityBusiness
2026-01-16
Company data provided by crunchbase